Interaction of antiepileptic drugs with human P-glycoprotein in vitro

About one-third of epilepsy patients are resistant to treatment with antiepileptic drugs (AEDs). This refractoriness is not fully understood, but is thought to be attributed to overexpression of multidrug transporters at the blood-brain barrier, particularly P-glycoprotein (Pgp). In certain cases ph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weiß, Johanna (VerfasserIn) , Kerpen, Christian Johannes (VerfasserIn) , Lindenmaier, Heike (VerfasserIn) , Dormann, Sven-Maria Gregor (VerfasserIn) , Haefeli, Walter E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 Oct 2003
In: The journal of pharmacology and experimental therapeutics
Year: 2003, Jahrgang: 307, Heft: 1, Pages: 262-267
ISSN:1521-0103
DOI:10.1124/jpet.103.054197
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1124/jpet.103.054197
Verlag, lizenzpflichtig, Volltext: https://jpet.aspetjournals.org/content/307/1/262
Volltext
Verfasserangaben:Johanna Weiss, Christian Johannes Kerpen, Heike Lindenmaier, Sven-Maria Gregor Dormann, and Walter Emil Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1758741201
003 DE-627
005 20240131165546.0
007 cr uuu---uuuuu
008 210526s2003 xx |||||o 00| ||eng c
024 7 |a 10.1124/jpet.103.054197  |2 doi 
035 |a (DE-627)1758741201 
035 |a (DE-599)KXP1758741201 
035 |a (OCoLC)1341413835 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
245 1 0 |a Interaction of antiepileptic drugs with human P-glycoprotein in vitro  |c Johanna Weiss, Christian Johannes Kerpen, Heike Lindenmaier, Sven-Maria Gregor Dormann, and Walter Emil Haefeli 
264 1 |c 1 Oct 2003 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.05.2021 
520 |a About one-third of epilepsy patients are resistant to treatment with antiepileptic drugs (AEDs). This refractoriness is not fully understood, but is thought to be attributed to overexpression of multidrug transporters at the blood-brain barrier, particularly P-glycoprotein (Pgp). In certain cases pharmacoresistance can be overcome by add-on therapy, raising the question of whether the coadministered drugs act as inhibitors of Pgp. Indeed, several AEDs are substrates and to some extent also inducers of Pgp. To date nothing is known about possible Pgp inhibitory activities of AEDs. Therefore, we investigated whether AEDs commonly used in mono or add-on therapy inhibit Pgp using a calcein acetoxymethylester uptake assay with L-MDR1 cells and primary porcine brain capillary endothelial cells, as well as confocal laser-scanning microscopy with L-MDR1 cells and bodipy-verapamil as Pgp substrate. In the calcein assay only carbamazepine inhibited Pgp, which was confirmed in confocal laser-scanning microscopy. In this assay, also phenytoin, lamotrigine, and valproate revealed Pgp inhibitory potency. Because Pgp inhibition by AEDs appeared at significantly higher concentrations than that of well known inhibitors and because the effective concentrations exceeded therapeutic AED plasma concentrations, Pgp inhibition appears not to be of clinical relevance, at least in antiepileptic monotherapy. However, it is possible that this inhibition may contribute to the effectiveness of certain add-on therapies. 
700 1 |a Kerpen, Christian Johannes  |d 1972-  |e VerfasserIn  |0 (DE-588)128821108  |0 (DE-627)38157105X  |0 (DE-576)297349368  |4 aut 
700 1 |a Lindenmaier, Heike  |e VerfasserIn  |0 (DE-588)1317608933  |0 (DE-627)1879501058  |4 aut 
700 1 |a Dormann, Sven-Maria Gregor  |d 1973-  |e VerfasserIn  |0 (DE-588)129032158  |0 (DE-627)387884572  |0 (DE-576)29745756X  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t The journal of pharmacology and experimental therapeutics  |d Bethesda, Md. : ASPET, 1909  |g 307(2003), 1, Seite 262-267  |h Online-Ressource  |w (DE-627)269534636  |w (DE-600)1475023-5  |w (DE-576)077884736  |x 1521-0103  |7 nnas  |a Interaction of antiepileptic drugs with human P-glycoprotein in vitro 
773 1 8 |g volume:307  |g year:2003  |g number:1  |g pages:262-267  |g extent:6  |a Interaction of antiepileptic drugs with human P-glycoprotein in vitro 
856 4 0 |u https://doi.org/10.1124/jpet.103.054197  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://jpet.aspetjournals.org/content/307/1/262  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210526 
993 |a Article 
994 |a 2003 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1758741201  |e 3931128873 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 26.05.2021"],"recId":"1758741201","type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Interaction of antiepileptic drugs with human P-glycoprotein in vitro","title":"Interaction of antiepileptic drugs with human P-glycoprotein in vitro"}],"name":{"displayForm":["Johanna Weiss, Christian Johannes Kerpen, Heike Lindenmaier, Sven-Maria Gregor Dormann, and Walter Emil Haefeli"]},"physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1124/jpet.103.054197"],"eki":["1758741201"]},"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"1 Oct 2003"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Bethesda, Md.","dateIssuedKey":"1909","publisher":"ASPET","dateIssuedDisp":"1909-"}],"language":["eng"],"disp":"Interaction of antiepileptic drugs with human P-glycoprotein in vitroThe journal of pharmacology and experimental therapeutics","title":[{"title_sort":"journal of pharmacology and experimental therapeutics","title":"The journal of pharmacology and experimental therapeutics","subtitle":"a publication of the American Society for Pharmacology and Experimental Therapeutics"}],"pubHistory":["1.1909/10 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 06.02.25","Fortsetzung der Druck-Ausgabe"],"recId":"269534636","part":{"extent":"6","year":"2003","pages":"262-267","text":"307(2003), 1, Seite 262-267","issue":"1","volume":"307"},"id":{"issn":["1521-0103"],"eki":["269534636"],"zdb":["1475023-5"]},"titleAlt":[{"title":"JPET online"}]}],"person":[{"family":"Weiß","given":"Johanna","role":"aut","roleDisplay":"VerfasserIn","display":"Weiß, Johanna"},{"display":"Kerpen, Christian Johannes","roleDisplay":"VerfasserIn","role":"aut","given":"Christian Johannes","family":"Kerpen"},{"display":"Lindenmaier, Heike","given":"Heike","roleDisplay":"VerfasserIn","role":"aut","family":"Lindenmaier"},{"display":"Dormann, Sven-Maria Gregor","roleDisplay":"VerfasserIn","role":"aut","given":"Sven-Maria Gregor","family":"Dormann"},{"display":"Haefeli, Walter E.","given":"Walter E.","roleDisplay":"VerfasserIn","role":"aut","family":"Haefeli"}],"language":["eng"]} 
SRT |a WEISSJOHANINTERACTIO1200